Qualigen Therapeutics (QLGN) Short Interest Ratio & Short Volume $4.37 +0.50 (+12.92%) (As of 01:51 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Qualigen Therapeutics Short Interest DataQualigen Therapeutics (QLGN) has a short interest of 15,600 shares, representing 3.14% of the float (the number of shares available for trading by the public). This marks a -85.84% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 93,746 shares to cover all short positions.Current Short Interest15,600 sharesPrevious Short Interest110,200 sharesChange Vs. Previous Month-85.84%Dollar Volume Sold Short$76,908.00Short Interest Ratio0.2 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares250,000 sharesFloat Size496,300 sharesShort Percent of Float3.14%Today's Trading Volume59,108 sharesAverage Trading Volume93,746 sharesToday's Volume Vs. Average63% Short Selling Qualigen Therapeutics? Sign up to receive the latest short interest report for Qualigen Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartQLGN Short Interest Over TimeQLGN Days to Cover Over TimeQLGN Percentage of Float Shorted Over Time Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Qualigen Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202415,600 shares $76,908.00 -85.8%3.1%0.2 $4.93 10/15/2024110,200 shares $17,951.58 +1.1%0.5%0.2 $0.16 9/30/2024109,000 shares $18,584.50 -60.5%0.5%0 $0.17 9/15/2024275,600 shares $45,363.76 -55.1%1.3%0 $0.16 8/31/2024613,400 shares $115,073.84 +84.4%2.4%0 $0.19 8/15/2024332,600 shares $65,522.20 +38.8%2.9%0 $0.20 Get the Latest News and Ratings for QLGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Qualigen Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024239,600 shares $53,263.08 -94.2%2.4%0 $0.22 7/15/20244,160,000 shares $1.61 million +627.9%40.9%0.3 $0.39 6/30/2024571,500 shares $98,469.45 +493.5%6.7%0.1 $0.17 6/15/202496,300 shares $19,163.70 +20.7%1.6%0.1 $0.20 5/31/202479,800 shares $21,546.00 +1.7%1.3%0.5 $0.27 5/15/202478,500 shares $24,083.80 +82.1%1.3%0.8 $0.31 4/30/202443,100 shares $12,921.38 -12.8%0.8%0.6 $0.30 4/15/202449,400 shares $15,808.00 -38.2%0.9%0.8 $0.32 3/31/202479,900 shares $31,960.00 +588.8%1.7%1.3 $0.40 3/15/202411,600 shares $4,294.32 +11.5%0.3%0.2 $0.37 2/29/202410,400 shares $4,785.04 -63.5%0.2%0.2 $0.46 2/15/202428,500 shares $13,523.25 -3.1%0.6%0.7 $0.47 1/31/202429,400 shares $15,452.64 -14.5%0.6%1.1 $0.53 1/15/202434,400 shares $17,595.60 +63.8%0.8%1.3 $0.51 12/31/202321,000 shares $11,550.00 -32.7%0.5%0.9 $0.55 12/15/202331,200 shares $18,033.60 -8.0%0.7%1.6 $0.58 11/30/202333,900 shares $25,052.10 -15.9%0.7%2.5 $0.74 11/15/202340,300 shares $28,250.30 +0.8%0.9%2.7 $0.70 10/31/202340,000 shares $31,108.00 +5.5%0.9%2.7 $0.78 10/15/202337,900 shares $35,091.61 -14.5%0.9%1.9 $0.93 9/30/202344,300 shares $44,743.00 +23.1%1.0%1.7 $1.01 9/15/202336,000 shares $37,800.00 +77.3%0.8%1.4 $1.05 8/31/202320,300 shares $21,112.00 -9.8%0.5%0.8 $1.04 8/15/202322,500 shares $24,525.00 -37.0%0.5%0.9 $1.09 7/31/202335,700 shares $40,341.00 +28.4%0.8%1.2 $1.13 7/15/202327,800 shares $30,749.58 -12.3%0.6%1.1 $1.11 6/30/202331,700 shares $28,878.70 +26.3%0.7%1.1 $0.91 6/15/202325,100 shares $24,098.51 -38.6%0.6%0.7 $0.96 5/31/202340,900 shares $37,746.61 +7.4%0.9%0.2 $0.92 5/15/202338,100 shares $38,862.00 -39.9%0.9%0.2 $1.02 4/30/202363,400 shares $59,507.24 -5.4%1.5%0.4 $0.94 4/15/202367,000 shares $63,650.00 -19.2%1.8%0.4 $0.95 3/31/202382,900 shares $76,690.79 +48.8%2.2%0.2 $0.93 3/15/202355,700 shares $56,257.00 -31.0%1.5%0.2 $1.01New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! 2/28/202380,700 shares $92,466.06 +41.6%2.1%0.3 $1.15 2/15/202357,000 shares $70,965.00 -17.2%1.5%0.2 $1.25 1/31/202368,800 shares $88,752.00 -61.2%1.8%0.3 $1.29 1/15/2023177,200 shares $237,448.00 +84.8%4.6%0.8 $1.34 12/30/202295,900 shares $123,615.10 No Change2.5%0.5 $1.29 12/15/202295,900 shares $136,178.00 +18.1%2.5%3.7 $1.42 11/30/202281,200 shares $121,597.00 -11.8%2.1%3.1 $1.50 11/15/202292,100 shares $20,308.05 -90.0%N/A4.3 $0.22 10/31/2022916,300 shares $201,586.00 -2.7%N/A4.3 $0.22 10/15/2022941,700 shares $253,128.96 -15.9%N/A4 $0.27 9/30/20221,120,000 shares $299,040.00 +25.5%N/A4.7 $0.27 9/15/2022892,200 shares $291,927.84 -11.7%N/A3.6 $0.33 8/31/20221,010,000 shares $384,406.00 -1.0%N/A4.3 $0.38 8/15/20221,020,000 shares $433,500.00 -8.9%N/A4.5 $0.43 7/31/20221,120,000 shares $469,056.00 -2.6%N/A4.8 $0.42 7/15/20221,150,000 shares $535,670.00 -2.5%N/A5.1 $0.47 6/30/20221,180,000 shares $672,246.00 -9.9%N/A1 $0.57 6/15/20221,310,000 shares $793,467.00 -9.0%N/A1.2 $0.61 5/31/20221,440,000 shares $807,840.00 +2.1%N/A1.3 $0.56 5/15/20221,410,000 shares $751,530.00 +13.7%N/A1.2 $0.53 4/30/20221,240,000 shares $706,800.00 -43.9%N/A1.1 $0.57 4/15/20222,210,000 shares $1.60 million +63.7%N/A1.8 $0.73 3/31/20221,350,000 shares $891,000.00 +3.9%N/A3.9 $0.66 3/15/20221,300,000 shares $741,000.00 -3.7%N/A0.7 $0.57 2/28/20221,350,000 shares $891,000.00 +2.3%N/A0.6 $0.66 2/15/20221,320,000 shares $970,860.00 -7.0%N/A0.2 $0.74 1/31/20221,420,000 shares $1.24 million -7.8%N/A0.2 $0.87 1/15/20221,540,000 shares $1.62 million -36.1%5.8%0.2 $1.05 12/31/20212,410,000 shares $2.58 million +33.9%9.3%0.3 $1.07 12/15/20211,800,000 shares $1.74 million -68.4%6.9%0.2 $0.96 11/30/20215,700,000 shares $8.38 million +258.5%22.1%0.8 $1.47 11/15/20211,590,000 shares $1.70 million -7.0%6.2%0.3 $1.07 10/29/20211,710,000 shares $1.97 million +4.3%6.7%3.8 $1.15 10/15/20211,640,000 shares $1.92 million -0.6%6.4%3.7 $1.17 9/30/20211,650,000 shares $2.15 million -0.6%6.4%3.5 $1.30 9/15/20211,660,000 shares $2.39 million +16.9%6.5%3.3 $1.44 8/31/20211,420,000 shares $2.23 million -18.9%5.5%2.7 $1.57 8/13/20211,750,000 shares $3.12 million -1.1%6.8%5.2 $1.78 7/30/20211,770,000 shares $3.13 million +2.3%6.9%5 $1.77 7/15/20211,730,000 shares $2.92 million +4.2%6.8%3.4 $1.69 6/30/20211,660,000 shares $3.30 million +9.2%6.5%2.7 $1.99 6/15/20211,520,000 shares $3.19 million -16.0%6.0%2.3 $2.10 5/28/20211,810,000 shares $3.46 million +0.6%7.1%2.5 $1.91 5/14/20211,800,000 shares $2.75 million -6.3%7.1%2.1 $1.53 4/30/20211,920,000 shares $4.22 million +7.9%7.5%1.6 $2.20 4/15/20211,780,000 shares $3.65 million No Change6.3%1.1 $2.05 3/31/20211,780,000 shares $4.63 million -11.4%6.2%1.1 $2.60 3/15/20212,010,000 shares $6.69 million +24.8%7.6%1.2 $3.33 2/26/20211,610,000 shares $5.47 million -10.6%6.1%0.8 $3.40 2/12/20211,800,000 shares $6.98 million -9.6%6.8%1 $3.88New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! 1/29/20211,990,000 shares $7.12 million +3.7%7.5%1.2 $3.58 1/15/20211,920,000 shares $6.62 million No Change7.3%1.5 $3.45 QLGN Short Interest - Frequently Asked Questions What is Qualigen Therapeutics' current short interest? Short interest is the volume of Qualigen Therapeutics shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 15,600 shares of QLGN short. 3.14% of Qualigen Therapeutics' shares are currently sold short. Learn More on Qualigen Therapeutics' current short interest. What is a good short interest percentage for Qualigen Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.14% of Qualigen Therapeutics' floating shares are currently sold short. Is Qualigen Therapeutics' short interest increasing or decreasing? Qualigen Therapeutics saw a decrease in short interest in October. As of October 31st, there was short interest totaling 15,600 shares, a decrease of 85.8% from the previous total of 110,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Qualigen Therapeutics' float size? Qualigen Therapeutics currently has issued a total of 250,000 shares. Some of Qualigen Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Qualigen Therapeutics currently has a public float of 496,300 shares. How does Qualigen Therapeutics' short interest compare to its competitors? 3.14% of Qualigen Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Qualigen Therapeutics: Guardion Health Sciences, Inc. (1.76%), CNS Pharmaceuticals, Inc. (3.41%), Biofrontera Inc. (12.12%), Pasithea Therapeutics Corp. (1.45%), Sonoma Pharmaceuticals, Inc. (4.14%), Tharimmune, Inc. (43.97%), Avenue Therapeutics, Inc. (3.74%), Genetic Technologies Limited (0.53%), Artelo Biosciences, Inc. (0.62%), Alaunos Therapeutics, Inc. (10.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Qualigen Therapeutics stock? Short selling QLGN is an investing strategy that aims to generate trading profit from Qualigen Therapeutics as its price is falling. QLGN shares are trading up $0.50 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Qualigen Therapeutics? A short squeeze for Qualigen Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of QLGN, which in turn drives the price of the stock up even further. How often is Qualigen Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including QLGN, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Guardion Health Sciences Short Interest Data CNS Pharmaceuticals Short Interest Data Biofrontera Short Interest Data Pasithea Therapeutics Short Interest Data Sonoma Pharmaceuticals Short Interest Data Tharimmune Short Interest Data Avenue Therapeutics Short Interest Data Genetic Technologies Short Interest Data Artelo Biosciences Short Interest Data Alaunos Therapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:QLGN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qualigen Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Qualigen Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free QLGN Stock Alerts